At Cure PDE Foundation, we are on a mission to empower and unite families affected by pyridoxine-dependent epilepsy (PDE) and
advance research to find a cure.
At Cure PDE Foundation, we are on a mission to empower and unite
families affected by pyridoxine-dependent epilepsy (PDE) and
advance research to find a cure.
Title
Learn about PDE
Empowering families
and igniting possibilities
Empowering families and
igniting possibilities
our mission
Living with a rare disease is full of anxiety and uncertainty. Our primary goal is to provide a place where someone else understands what you are going through.
community & Events
Whether it's funding research, advocating for better testing, or creating a strong community where hope thrives, we stand together as a force of change. With CurePDE, you'll find the support and resources needed to face PDE with courage, strength, and the knowledge that you are not alone in this journey.
But sometimes, you want to be empowered to do more:
At Cure PDE, we understand the challenges of living with pyridoxine-dependent epilepsy (PDE).
Empowering Hope, Uniting Families, and Advancing Research
Our goal at CurePDE is to provide information on the latest research on the scientific aspects of PDE and the biotechnological innovations used to address rare genetic diseases. We also believe it is important to translate this information into something we can all understand and benefit from, so we aim to summarize it in a friendly way. If you would like to discuss these publications in more scientific depth, please reach out; we would be happy to do that as well.
Stay up to date with the latest research
Great news for those affected by rare metabolic disorders! Moderna’s new investigational treatment for methylmalonic acidemia (MMA), and work with Propionic Acidemia. This initiative aims to accelerate the development of promising therapies for rare diseases.
Dr. Houten’s work on substrate reduction therapy for GA1 and its implications for related pathways such as PDE offers a glimpse into the future of treatment for rare genetic disorders.
We are thrilled to extend a warm invitation to all of you for an upcoming Zoom meeting designed to bring us closer together.
We’re excited to share a unique opportunity for you to contribute directly to the future of PDE research.
Big news – we’re hosting our FIRST webinar on Pyridoxine-Dependent Epilepsy (PDE) research on January 25th, and you’re invited!
This blog post introduces the CHARLIE Consortium, a group of researchers dedicated to studying Pyridoxine-Dependent Epilepsy (PDE).
Our goal at CurePDE is to provide information on the latest research on the scientific aspects of PDE and the biotechnological innovations used to address rare genetic diseases. We also believe it is important to translate this information into something we can all understand and benefit from, so we aim to summarize it in a friendly way. If you would like to discuss these publications in more scientific depth, please reach out; we would be happy to do that as well.
Stay up to date with the latest research
Great news for those affected by rare metabolic disorders! Moderna’s new investigational treatment for methylmalonic acidemia (MMA), and work with Propionic Acidemia. This initiative aims to accelerate the development of promising therapies for rare diseases.
Dr. Houten’s work on substrate reduction therapy for GA1 and its implications for related pathways such as PDE offers a glimpse into the future of treatment for rare genetic disorders.
Meet Andre
meet the Cure pde founders
Creating a Community for Pyridoxine-Dependent Epilepsy
At CurePDE, we are on a mission to empower and unite families affected by pyridoxine-dependent epilepsy (PDE). We strive to advance research, unlock knowledge, and foster a supportive community where hope thrives. Together, we believe in a future where effective treatments and a cure for PDE are within reach. Join us as we stand strong, hand in hand, empowering each other to create a brighter tomorrow for everyone impacted by PDE.
Read more about Cure PDE Founders
read andre's story
Meet Andre
Our story began on 17 July 2011. My son Andre was born at Cedars-Sinai Medical Center, Los Angeles, CA. My pregnancy was unremarkable as my doctor never saw any problem with the health of Andre and myself.
"A chain of different specialists visited Andre during the next two weeks but none had been able to recognize a pyridoxine deficiency."
Learn about PDE
Our blog is a warm and welcoming space where families touched by PDE can freely share their unique journeys, experiences, and triumphs, believing that every story holds the power to inspire, educate, and unite.
real people, real stories
share your story
view all stories
© 2023 Cure PDE Foundation | All Rights Reserved | Terms of Use | Privacy Policy
get in touch
Join the Community
Contact
Information
Our Team
About PDE
About Our Foundation
Get involved
Real People, Real Stories
Community & Events
Research & Education
